Glycomic Therapeutics Market

Glycomic Therapeutics Market Outlook (2022-2032)

The global glycomic therapeutics market is expected to expand at a CAGR of 16.1% during the period 2022-2032. The market is expected to hold a valuation of US$ 551,756 million by 2032, and as of 2022, the market is valued at US$ 124,439 million.

“The demand for glycomic therapeutics is mainly driven by an urge for easy methods for cancer diagnosis, development of an antimicrobial vaccine, drug development, and plenty of other factors.”

One of the most important applications of glycomic therapeutics is that it is used for cancer diagnostics. The global cancer diagnostics market is valued at US$ 171 billion as of 2022 and is expected to grow at a CAGR of nearly 7.5% through 2032. This might well increase the sales of glycomic therapeutics during the forecast period.

Furthermore, patients across the world are relying more on are on personal medication. This is owing to the fact that personal medication is a cost-effective form of treatment and provides patients with the necessary medication based on their genetic profile.

The glycomics is being used for the manufacturing of certain pills pertaining to obesity and hypertension. Owing to the penetration of the internet, patients carry out self-research and can decide on the pills that can work for them. This is expected to increase the adoption of glycomic therapeutics during the forecast period.

Moreover, glycomics therapeutics are also found to be effective in certain kinds of treatments like congenital disorders, growth defects, etc. It has been found that the alteration in glycans generally leads to such conditions. This might as well have a positive influence on the glycomic therapeutics adoption trends.

The glycomics is used alongside proteomics for offering effective therapeutics. There has been an increase in the demand for proteomics, and the proteomics market is expected to grow at a robust CAGR of nearly 17%. This represents a huge opportunity for the glycomic therapeutics market.

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Get FREE Report Sample

Key Market Drivers for Glycomic Therapeutics Market

There are a number of measures being taken by manufacturers worldwide to increase the sales of glycomic therapeutics. The adoption of Artificial Intelligence, coupled with data analytics, is expected to surge the market growth during the forecast period.

Technological advancements in healthcare sector

The key driver happens to be massive technological advancements in the healthcare sector.

A study published in frontiersin.org dated 23rd July’21 mentioned how the advancements in mass spectrometry technology-based glycomic and glycoproteomic studies assisted in the diagnosis of pancreatic diseases. The researchers are of the view that mass spectrometry is one of the most powerful tools, which is expected to revolutionize glycomic therapeutics going ahead.

Increased investment in research and development

Be it the key players or the governments, the organizations are investing massive amounts in R&D to develop novel methods pertaining to glycomic therapeutics.

In February 2022, the National Science Foundation awarded US$ 23 million for a multi-university partnership which was led by Virginia Tech and the University of Georgia for fast-tracking glycomaterials-based research in the USA.

Increased adoption in antimicrobial vaccine

The glycomic therapeutics are used in the manufacturing of antimicrobial vaccines as well. The global antimicrobial vaccine market is expected to reach a valuation of nearly US$ 6.8 billion by 2032.

The glycomic therapeutics are used as a vaccine against bacterial infections and cancer cells.

Used for drug discovery

The key players involved in the healthcare sector are investing huge amounts in glycomic therapeutics as these help in the process of drug delivery. The global drug delivery market is expected to grow at a CAGR of nearly 10% during the forecast period.

An increase in the number of people suffering from lifestyle diseases like BP, diabetes, neurological disorders, etc., is expected to surge the drug discovery market. The glycans assist in protein folding and stability and act as recognition elements in cell-cell and cell-matrix interactions. Consequently, these are being increasingly used in the process of drug delivery.

Increased government initiatives

Apart from investing in the technological and R&D aspects, the government is carrying out various other forms of initiatives. There are awareness programs being conducted by governments across the world to increase awareness regarding the benefits of glycomic therapeutics.

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

Get a Customized Version

Restraints for the Glycomic Therapeutics Market

High cost

One of the biggest restraints for the market is the high cost associated with the procedure. The application of certain instruments, like mass spectrometers, makes the entire process quite expensive.

Lack of skilled professionals

There is a scarcity of skilled professionals in the market. Being a rising market and having a lack of awareness about the existence of such a method are some of the reasons why there are very few professionals associated with the market.

Apart from that, being a highly complicated field of study is also one of the reasons why very few people are able to take up the core profession.

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Exponential Increase in the number of collaborations between various Academic and Research Institutes presents Massive Opportunity

Based on the market research, it was found that the research and academic institutes have been making massive contributions to the market. It is owing to the fact that they have been making huge investments in the Research and Development of innovative methods.

Furthermore, it was also observed that the research institutes have been making increased usage of data analysis of glycomic structures. Furthermore, preferring glycomics for educational purposes is also expected to drive the market.

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert

I'm Available

Category-wise Insights

Class Insights

On the basis of class, the synthetic segment is expected to have the highest market share during the forecast period. This is owing to the fact that they have been instrumental in creating novel biological processes with compositions not found in nature.

However, it is the isolated segment that is expected to grow with the highest CAGR of nearly 17.6% during the forecast period.

Structure Insights

On the basis of structure, the glycoproteins segment is expected to have the highest market share during the forecast period. The glycoproteins are known to assist in the crucial tasks of reproduction, taking care of the immune system and hormones, and also protecting cells and organisms.

However, based on the research, it was found that targeting the sialic acid segment is expected to grow at the highest CAGR. This is mainly because of the fact that these are believed to be the key hormones that modulate immune responses.

Indication Insights

Based on the indication, influenza types A and B are expected to hold the highest market share during the forecast period. One of the key reasons is because of the fact that both influenza A and B are highly contagious.

These are known to cause seasonal flu epidemics in the USA almost every year and affect even animals. However, the emphasis is more on Influenza A than on Influenza B, as the mutation in influenza B is much slower than in Influenza A.

Mode of Action Insights

Based on the mode of action, erythropoietin and Enzyme Replacement Therapy (ERT) is projected to have the largest market share during the forecast period. It is because of the fact that there are increasing cases wherein patients are in need of Red Blood Cells. Erythropoietin helps in maintaining a healthy amount of Red Blood Cells.

The inhibits neuraminidase segment is expected to register the highest CAGR during the forecast period.

Comparative View of Glycomic Therapeutics Market

Comparative View of Glycolic acid Market

Comparative View of Glycomics Market

Country-wise Insights

USA

On a country-wise basis, the USA is expected to be the largest market for glycomic therapeutics during the forecast period. The North American region is expected to be the largest market for glycomic therapeutics. The presence of a technologically evolved healthcare sector makes the USA one of the hottest markets.

Apart from that, the region is also meant to produce a skilled workforce, coupled with massive initiatives to increase awareness regarding glycomic therapeutics.

Furthermore, the region is also home to a huge number of diabetic patients in the world. Based on an article from Medical News Today, there are nearly 338 million diabetic patients, which is the third largest worldwide. All these factors make the USA a huge market for glycomic therapeutics.

Europe

Europe is expected to be one of the most significant markets during the forecast period. The region has been witnessing a huge number of collaborations between research and academic institutions, which shows a lot of scope for the market.

Furthermore, the region is also meant for the largest number of cancer patients in the world. With glycomic therapeutics being widely used in cancer detection, the region holds a lot of scope for the market.

Moreover, the region has also been reporting a huge number of congenital disorders in recent years. This as well is expected to increase the adoption of glycomic therapeutics during the forecast period.

Japan

Japan presents a lot of scope to the glycomic therapeutics market. Being virtually the technological capital of the world, Japan has a massive market for personal medication. That is because of a lot of developments taking place in genetic research.

Furthermore, the key players operating in Japan are investing a lot in the development of various methods to treat lifestyle diseases like hypertension, diabetes, BP, etc. This is also expected to present a lot of scope to the market during the forecast period.

South Korea

South Korea region is currently one of the most dynamic markets for glycomic therapeutics. Furthermore, the region has been witnessing an influx of skilled professionals. This is expected to increase the demand for glycomic therapeutics during the forecast period.

Moreover, even the South Korean government has been taking proactive steps to provide the best healthcare facilities. Apart from that, the country has also been witnessing a surge in cancer cases, which is also expected to surge the market growth during the forecast period.

Recent Developments

The market is witnessing a lot of strategic partnerships, between the key players and the players operating in other segments of healthcare sector. Apart from that, the market has also been experiencing a number of mergers. The main reasons are expanding the footprints of the market, and also to access certain technologies which were not available with them.

Some of the recent developments are:

• In August 2022, the New England Biolabs introduced Faustovirus Capping Enzyme, a Novel Enzymatic mRNA capping solution for mRNA manufacturing.
• In October 2022, GSK marketing authorization application for respiratory syncytial virus older adult vaccine candidate accepted by Europe Medicines Agency.

Report Scope

Glycomic Therapeutics Market Segmentation

By Class:

• Isolated
• Synthetic

By Structures:

• Glycoproteins
• Targeting Sialic Acid
• Proteoglycans
• Targeting Glycosaminoglycans
• Targeting Glycosylphosphatidylinositol (GPI) – Anchored Proteins and Heparin Based Glycans
• Targeting Glycosphingolipids
• Others

By Indications:

• Thrombosis and Chemoprophylaxis
• Anaemia
• Anti-adhesive and Anti-inflammatory
• Cataracts
• Gaucher’s disease
• MPS-1 and IV
• Cancer
• Alzheimer’s disease
• Influenza type A and B
• Others

By Mode of Action:

• Inhibits Neuraminidase
• Inhibits Heparanase and Selectins and Blocks Interactions between Growth Factors and Heparan Sulfate
• Erythropoietin and Enzyme Replacement Therapy
• Tissue Plasminogen Activator
• Inhibits Glucosylceramide Synthase
• Interleukin 1, 2 & 3
• Beta and Gamma Interferons
• Others

By Region:

• North America
• Latin America
• Asia Pacific
• MEA
• Europe